Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
8.72
-0.06 (-0.68%)
Nov 14, 2025, 3:22 PM EST - Market open
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $312.71 million as of November 14, 2025. Its market cap has decreased by -48.57% in one year.
Market Cap
312.71M
Enterprise Value
46.16M
1-Year Change
-48.57%
Ranking
Category
Stock Price
$8.72
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $312.71M, an increase of 24.58%. That is a compound annual growth rate of 5.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 314.86M | -48.56% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 911.30B |
| Johnson & Johnson | 468.34B |
| AbbVie | 412.21B |
| UnitedHealth Group | 307.13B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 226.98B |
| Abbott Laboratories | 224.00B |